The ODAC minutes (in hindsight) is a very poor reflection on Mesoblast. It was all Fred Grossman.......?
Don't go and find the interview SI did shortly after where he loses his shiate........because that is even more eye-opening in retrospect. He regained his composure shortly after and as such, the interview I am referring to 'didn't happen....'.
Humans. Flawed. Who would of thought.
Scientific 'gods' that drop their drawers to take a 'mesenchymal stem cell', just like the rest of us.
I do see your point and I am hopeful that the many meetings since then and the many submissions since then and the many ten's of millions of US dollars spent and the involvement of Krause and the treatment of the kids by the very same cells in the almost 4 years since and the recent agreement of the FDA to accept the revamped BLA would of altered the status that you are referring.
Am I sure? No - Mesoblast doesn't tell us much at all and they have played word games with shareholders and the market for years. It is a freaking joke. I've called this business a hobby farm for years - I'm yet to be shown any different.
What is Mesoblast doing today? Whatever took SI's fancy, after he woke up, scratched his nuts and took a mesenchymal stem cell. And that's just how the whole of Mesoblast likes it!
The market has risen on a swag of circumstantial evidence. I've been burnt by this type of situation by these same people before, but, I tentatively say that I reckon this will soon be a goer. And I suspect/hope that it will go and go and go.
Don't rely on anything I say as this company has a long track record of disappointment and the people running it are from another planet, in another galaxy.
Fool me once, blah, blah, blah.....if this goes bad, this one's on me, as I should of known better.
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-387
-
- There are more pages in this discussion • 710 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.46 |
Change
0.010(0.69%) |
Mkt cap ! $1.667B |
Open | High | Low | Value | Volume |
$1.46 | $1.49 | $1.44 | $3.472M | 2.379M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 12398 | $1.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.47 | 5440 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 12398 | 1.460 |
2 | 19558 | 1.455 |
5 | 49977 | 1.450 |
5 | 102249 | 1.445 |
2 | 30389 | 1.440 |
Price($) | Vol. | No. |
---|---|---|
1.465 | 5440 | 3 |
1.470 | 22187 | 2 |
1.475 | 84389 | 3 |
1.480 | 118230 | 9 |
1.485 | 96793 | 8 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online